Tampa, FL, May 8-10, 2008
Note: Unless noted otherwise, physician, nurse, psychologist, and pharmacist credit will be offered.
Thursday, May 8
8-8:30 am
Keynote Address: The Neurobiology of Pain
Allan Basbaum, PhD
.5 CME/CE *
8:30-9 am
State of the Society
Judith Paice, PhD RN FAAN
9-9:30 am
Plenary Session: Chronic Pain in Adults: Is It Influenced by Early Life Events?
Gary Macfarlane, MD
.5 CME/CE *
9:30-11 am
Welcome Reception in Exhibit Hall
11:15 am-12:45 pm
Symposia
(301) Genetic Variations in Susceptibility to Chronic Pain
and Pain Processing
Cielito Reyes-Gibby, DrPH (Moderator); Michael Costigan; PhD, Jeffrey
Mogil, PhD; Jon-Kar Zubieta, MD PhD
1.5 CME/CE
This symposium will present animal and human studies
assessing genetic influences to chronic pain and pain
processing.
(302) Opiate Dosing Guidelines: Outrage or Imperative
Gregory Terman, MD PhD (Moderator); Gary Franklin, MD MPH;
Jane Ballantyne, MD FRCA; Scott Fishman, MD; Mark Sullivan, MD PhD
1.5 CME/CE
Washington State recently developed and issued the Washington
State Interagency Guideline on Opioid Dosing for Chronic Non-Cancer
Pain. This session will explore the guideline and its development,
review the risks and benefits of opiate treatment for
chronic noncancer pain, and discuss the role of guidelines in
pain management.
(303) Acute Pain in the Emergency Department: Clinical Practice, Research, and Development
Peter Lacouture, PhD (Moderator); Knox Todd, MD MPH;
David Hewitt, MD; Bob Rappaport, MD
1.5 CME/CE
The nature and practice of acute pain management in the
emergency room is becoming increasingly important.
Opportunities and challenges for conducting meaningful
research in this unique setting will be examined and recent
experience reviewed. Regulatory and scientific aspects used to
develop a new model for evaluating acute pain treatments will
be explored.
(304) Management of Intractable Pain in Children with Life-Limiting Conditions
Stefan Friedrichsdorf, MD (Moderator); Charles Berde, MD PhD;
Christine Gibbon, PhD LP
1.5 CME/CE
A large number of children with intractable pain at the end
of life require “broad-spectrum analgesia”—pharmacological
(i.e., nonopioids, opioids, adjuvants), integrative nonpharmacological,
and, rarely, invasive treatment modalities. Some children display poor responses to opioid dose escalation; age dependence of opioid tolerance and opioid-induced hyperalgesia will be discussed.
(305) The Persistence of Pain: Long-Term Potentiation, Central Sensitization, and Pain Memory
Bryan Hains, PhD (Moderator); Júrgen Sandkúhler, MD PhD;
Vania Apkarian, PhD
1.5 CME/CE
This symposium will focus on how chronic pain is related to
learning and memory. Recent experimental and clinical findings
related to long-term potentiation in nociceptive neurons,
molecular and cellular remodeling of dendritic spines in
nociceptive structures in a manner consistent with memory
consolidation, and the formation of pain memory traces in the
human cortex will be reviewed.
(306) Traumatic Onset of Chronic Pain
Allen Lebovits, PhD (Moderator); Brian Hainline, MD;
Steven Cohen, MD; Dennis Turk, PhD
1.5 CME/CE
As medical advances have increased the rates of survival
subsequent to traumatic events, the prevalence of chronic
pain as a sequela of trauma has also increased. Thus, patients
with chronic pain often have a traumatic onset etiology. This
symposium will review the prevalence, treatment, and possible
prevention of chronic pain following trauma resulting from
three very different environments: the sporting arena, the
battlefield, and the highway.
2:45-4:15 pm
Symposia and Paper Presentations
(307) Risk Factors for Onset and Persistence of Pain
(307) Risk Factors for Onset and Persistence of Pain
Roger Fillingim, PhD (Moderator); Robert H. Dworkin, PhD; Samuel
McLean, MD MPH; Gary Macfarlane, MD
1.5 CME/CE
Speakers will present information about clinical, genetic, physiological,
and psychosocial risk factors for the development of
chronic pain. Evidence from epidemiologic research, studies
of motor vehicle accident victims, and evaluation of patients
undergoing surgery will be presented, and implications for
early identification and prevention will be discussed.
(308) Cooling-Activated TRP Channels in Physiological and Pathological Cold Sensation
Robert W. Gereau IV, PhD (Moderator); Ajay Dhaka, PhD; Thomas Voets,
PhD; Jianguo Gu, MB PhD
1.5 CME/CE
The speakers will discuss the mechanisms by which temperatures
and environmental irritants can activate TRP channels
and will also discuss animal behavioral studies that address
the potential role of these channels in physiological and pathological
cold sensation.
(309) Methadone: Science, Clinical Use, and Public Policy
Scott Strassels, PharmD PhD (Moderator); Gavril Pasternak, MD PhD;
Douglas Weschules, PharmD BCPS; Thomas Hazlet, PharmD DrPH
1.5 CME/CE
Speakers will discuss the recent advances in knowledge of opioid
biology, important issues related to the clinical use of methadone,
and public policy implications of methadone use.
(310) Biofeedback: Past, Present, and Future
Sean Mackey, MD PhD (Moderator); Robert Gatchel, PhD ABPP;
Richard Robinson, PhD
1.5 CME/CE
This symposium will review the history of biofeedback,
assumed mechanisms, and evidence of efficacy. Presenters will
discuss traditional biofeedback, EEG biofeedback, and recent
evidence on neuroimaging feedback.
(311) Use of E-Health Technologies in the Assessment and Management of Pediatric Pain
Jennifer Stinson, PhD RN CPNP (Moderator); Tonya Palermo, PhD;
Mark Connelly, PhD
1.5 CME/CE
Speakers will review the use of novel e-health technologies to
improve the assessment (e.g., electronic diaries) and management
(e.g., Web- and CD-ROM-based interventions) of pain in
children and adolescents.
(312) Evidence-Based Medicine for Evaluation and Management of Low Back Pain: Update on Guidelines from the American Pain Society
Roger Chou, MD (Moderator); Rick Rosenquist, MD; John Loeser, MD
1.5 CME/CE
APS, in collaboration with the American College of Physicians,
published new evidence-based guidelines for the management
of low back pain in primary care in October 2007. Guidelines for
using interventional therapies and surgery will be completed in
spring 2008.
(313) Paper Presentations: Molecular and Systems Biology
1.5 CME/CE
6-7:30 pm
SIG Meetings
(120) Basic Science
A brief report on the SIG’s progress and activities throughout the year will take place and be followed by an open discussion from the floor and election of a new co-chair for 2008-2009. The content of the 2009 Basic Science Dinner Symposium will be addressed and a data blitz featuring three early career scholars—Michael Lacroix-Fralish, PhD; Sacha Malin, PhD; and Heather Wenk, PhD—will conclude the meeting.
(121) Ethics and Philosophy
A speaker will present a current ethical issue in pain management, and group case discussions will follow. Updates on ethical standards in pain management will be available.
(122) Geriatric Pain
The meeting will include a special lecture, “Issues in the Pathophysiology and Treatment of Pain in the Geriatric and Frail Population.”
(123) Palliative Care
(124) Pain in Infants, Children, and Adolescents
(125) Pharmacotherapy
A discussion of various topics and brief presentations from three to four early professionals on their research findings will be followed by a brief data blitz. Reports will be given by SIG members who serve on the Annual Meeting Scientific Programming Committee and the Education Advisory Committee as well as the liaison to the APS Board of Directors. Nominations for the 2008-2009 chair and co-chair positions will take place and there will be time for open discussion from the floor.
(126) Psychosocial Research
Up to 10 members will present data on new research that they are conducting. The format will encourage an open exchange between presenters and the audience. The session will also include some discussion of recently developed bylaws and the election of a new co-chair.
7:30-10:30 pm
Clinical Centers of Excellence and Awards Gala
* Not eligible for pharmacist credit.
